Guillem Laporta, CFA, Principal, Ysios Capital emphasizes “risk of permanent loss” and what investors really care about. Farmantra Share this post 29th November 2018 Related Post 1 OCTOBER, 2025Value creation in Life...Investors in biotech often...101 OCTOBER, 2025Not a Book Review – 5Are you tempted to interrupt...202 OCTOBER, 2025Value creation in Life...Ever tried a new roast from a...102 OCTOBER, 2025Not a Book Review – 4Have you witnessed the...10